🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Surgical resection is one of the curative treatment modalities for HCC. Lim...
Status
Completed
Location
University Hospital
Start Date
2013-04
Trial ID
NCT02021253
This is a study to determine the safety and tolerability of 28 days of dail...
Status
Completed
Location
Multiple Locations
Start Date
2008-06-24
Trial ID
NCT00775138
Treatments Being Tested
A Phase 1 study will test the safety, tolerability and pharmacokinetics of ...
Status
Completed
Location
Nucleus Network Limited
Start Date
2016-07-26
Trial ID
NCT03096756
To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) exte...
Status
Completed
Location
Xenoscience, Inc. (102)
Start Date
2018-11-06
Trial ID
NCT03670953
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of di...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2006-11
Trial ID
NCT00389376
This Phase 3 multinational, randomized, double-blind study is designed to c...
Status
Completed
Location
The University of Arizona Cancer Centre-North Campus
Start Date
2017-06-19
Trial ID
NCT03112174
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of PCI-327...
Status
Completed
Location
Multiple Locations
Start Date
2014-01-31
Trial ID
NCT01974440
The purpose of this study is to measure how well monoclonal antibodies work...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-10-29
Trial ID
NCT04634409
Treatments Being Tested
This is a study to determine the safety and tolerability of 28 days of dail...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00558844
Treatments Being Tested
First, it will be evaluated whether supplementation of eriocitrin reduces h...
Status
Completed
Location
Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas
Start Date
2017-07-02
Trial ID
NCT03215043
Treatments Being Tested